Advertisement
Advertisement
BLTE
Belite Bio, Inc - ADR
152.52
USDSponsored
-3.56
-2.28%
Oct 08, 15:59 UTC -4
Closed
After-Market
152.19
-0.34
-0.22%
BLTE Earnings Reports
Positive Surprise Ratio
BLTE beat 6 of 16 last estimates.
38%
Next Report
Date of Next Report
Nov 09, 2026
Estimate for Q3 26 (Revenue/ EPS)
--
/-$0.78
Implied change from Q2 26 (Revenue/ EPS)
--
/+11.43%
Implied change from Q3 25 (Revenue/ EPS)
--
/+20.00%
Belite Bio, Inc - ADR earnings per share and revenue
On Aug 12, 2026, BLTE reported earnings of -0.70 USD per share (EPS) for Q2 26, beating the estimate of -0.80 USD, resulting in a 12.99% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -2.09% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 6 analysts forecast an EPS of -0.78 USD, with revenue projected to reach -- USD, implying an increase of 11.43% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Nanobiotix S.A. - ADR
Report Date
Sep 25, 2026 For Q2 26
Estimate
-$0.11
Actual
-$0.70
Surprise
-496.76%
Inventiva S.A. - ADR
Report Date
Sep 28, 2026 For Q2 26
Estimate
-$0.37
Actual
-$0.25
Surprise
+33.55%
Rezolute, Inc. Common Stock (NV)
Report Date
Sep 24, 2026 For Q4 26
Estimate
-$0.15
Actual
-$0.20
Surprise
-32.45%
Palatin Technologies, Inc. Common Stock
Report Date
Sep 28, 2026 For Q4 26
Estimate
-$1.21
Actual
-$1.11
Surprise
+8.42%
NeuroSense Therapeutics Ltd. Ordinary Shares
Report Date
Sep 25, 2026 For Q2 26
Estimate
-$3.26
Actual
-$2.10
Surprise
+35.66%
FAQ
What were Belite Bio, Inc - ADR's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Belite Bio, Inc - ADR reported EPS of -$0.70, beating estimates by 12.99%, and revenue of $0.00, 0% as expectations.
How did the market react to Belite Bio, Inc - ADR's Q2 2026 earnings?
The stock price moved down -2.09%, changed from $166.28 before the earnings release to $162.80 the day after.
When is Belite Bio, Inc - ADR expected to report next?
The next earning report is scheduled for Nov 09, 2026.
What are the forecasts for Belite Bio, Inc - ADR's next earnings report?
Based on 6
analysts, Belite Bio, Inc - ADR is expected to report EPS of -$0.78 and revenue of -- for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.